But a new antibiotic from Swiss pharmaceutical company Roche could change the future of how we treat Gram-negative bacteria. Roche announced on Monday that its antibiotic zosurabalpin will enter phase ...
A new global review uncovers why many low- and middle-income countries struggle to produce up-to-date, evidence-based antibiotic guidelines, and how adopting WHO-backed strategies could be the key to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results